Major General James G. Blunt

Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.[1] It acts as an antimuscarinic agent.[2][3] It was first approved in 1954 and is no longer marketed in the United States.[1]

References

  1. ^ a b "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
  2. ^ "Piperidolate". drugs.com.
  3. ^ Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.



source: https://en.wikipedia.org/wiki/Piperidolate